Home

FOR ADVANCED BIOTHERAPEUTICS

HIGH PERFORMANCE CELL TECHNOLOGY

STABLE AAV PRODUCER CELL LINES

ELEVECTA®

CEVEC Pharmaceuticals is a leading provider of high-performance cell technology for the manufacturing of advanced biotherapeutics from R&D to manufacturing scale.

The company’s product portfolio comprises platform technologies for gene therapy viral vectors, viral vaccines, Exosomes and complex recombinant proteins. ELEVECTA® is specifically designed for AAV manufacturing, while CAP® addresses Adenoviral vectors, Lentiviral vectors, Oncolytic viruses and Exosomes. CAP®Go is the platform of choice for complex recombinant proteins.

STABLE AAV PRODUCER CELL LINES

VIRAL VECTORS, VACCINES AND EXOSOMES

GLYCO-OPTIMIZED PROTEINS

CEVEC signs agreement with Roche for the use of CEVEC’s ELEVECTA® Technology in gene therapy

Cologne, Germany, November 10, 2020

J.P. MORGAN 39th Annual Conference
VIRTUAL CONFERENCE

January 11 – 14, 2021

NEWSLETTER

Subscribe for the CEVEC Newsletter according to our Privacy Policy to receive the latest CEVEC News,
including Press Releases, Conference Information and Webinar Invitations.

© CEVEC Pharmaceuticals GmbH 2020